At the news
? NEUTRALIMPACT 2/10 144 filed Nov 9, 2026 at 17:35 ET
Director Joseph P. Slattery filed a Form 144 notice of intent to sell 5,200 shares of Replimune Group common stock, with an approximate market value of $113,360. The sale is small relative to the company's $1.9B market cap and represents a routine diversification move by a director.
- Joseph P. Slattery, a director, filed Form 144 to sell 5,200 shares of common stock.
- Estimated aggregate market value of the proposed sale is $113,360.
- Shares were acquired on 07/20/2018 via exercised shares from the issuer.
- The proposed sale date is 11/09/2026.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access